|
CENPBD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.80896999999458E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.22319999999754E-05 |
| Normal-vs-Stage2 |
6.692200E-01 |
| Normal-vs-Stage3 |
7.21090000044278E-07 |
| Normal-vs-Stage4 |
5.52200000000225E-05 |
| Stage1-vs-Stage2 |
9.032700E-04 |
| Stage1-vs-Stage3 |
5.778000E-02 |
| Stage1-vs-Stage4 |
1.106800E-01 |
| Stage2-vs-Stage3 |
3.69500000000356E-05 |
| Stage2-vs-Stage4 |
4.368300E-04 |
| Stage3-vs-Stage4 |
8.698600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.74979999995251E-06 |
| Normal-vs-AfricanAmerican |
3.776600E-03 |
| Normal-vs-Asian |
9.016900E-03 |
| Caucasian-vs-AfricanAmerican |
5.971800E-01 |
| Caucasian-vs-Asian |
3.916800E-01 |
| AfricanAmerican-vs-Asian |
3.231800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.159920E-04 |
| Normal-vs-Female |
3.7763000000024E-05 |
| Male-vs-Female |
8.151400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.29859999999471E-05 |
| Normal-vs-Age(41-60Yrs) |
5.622100E-04 |
| Normal-vs-Age(61-80Yrs) |
2.361900E-04 |
| Normal-vs-Age(81-100Yrs) |
2.964000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.418400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.356000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.831000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.511600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.684400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.364800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.02840000000215E-05 |
| Classical-VS-Follicular |
1.596960E-01 |
| Classical-VS-Other |
4.985200E-01 |
| Classical-VS-Normal |
3.66750000000415E-05 |
| Tall-VS-Follicular |
2.3941999999999E-05 |
| Tall-VS-Other |
6.021200E-01 |
| Tall-VS-Normal |
1.13470000062676E-08 |
| Follicular-VS-Other |
3.230400E-01 |
| Follicular-VS-Normal |
2.844300E-02 |
| Other-VS-Normal |
4.969800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.660500E-03 |
| Normal-vs-N1 |
6.33099999980402E-07 |
| N0-vs-N1 |
3.441400E-04 |
|
|
